Company / Financials
Neurogene Inc. Financials
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$925.0K
FY2025
Net Income
-$75.1M
FY2025 · -106.9% YoY
Profit Margin
-8123.7%
FY2025 · net income / revenue
ROE
-24.2%
FY2025 · return on equity
Total Assets
$288.6M
FY2025
Total Debt
-
FY2025
Equity
$310.4M
FY2025
ROA
-26.0%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.24 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$925.0KNet Income HistoryProfit after all expenses and taxes-$75.1M-106.9% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$82.6M-48.6% YoYSG&A Expense HistorySelling, general, and administrative expenses$22.6M+102.1% YoYR&D Expense HistoryResearch and development spending$60.9M+37.2% YoYInterest Expense HistoryCost of borrowing and debt obligations-Income Tax HistoryTotal income tax expense$0EPS (Basic) HistoryBasic earnings per share-$4.280.0% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-$4.280.0% YoYShares Outstanding HistoryWeighted average diluted shares outstanding14.9M+15.8% YoY